These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35257383)

  • 21. Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.
    Chen CH; Lin CL; Kao CH
    Osteoporos Int; 2016 Jun; 27(6):2117-26. PubMed ID: 26860609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study.
    Fraser LA; Leslie WD; Targownik LE; Papaioannou A; Adachi JD;
    Osteoporos Int; 2013 Apr; 24(4):1161-8. PubMed ID: 22890365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cohort study of thiazolidinediones and fractures in older adults with diabetes.
    Solomon DH; Cadarette SM; Choudhry NK; Canning C; Levin R; Stürmer T
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2792-8. PubMed ID: 19470635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton pump inhibitor use and the risk of fractures among an older adult cohort.
    Harding BN; Weiss NS; Walker RL; Larson EB; Dublin S
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):596-603. PubMed ID: 29493043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diabetes mellitus and osteoporosis. Effect of antidiabetic medicine on osteoporotic fracture].
    Hayakawa N; Suzuki A
    Clin Calcium; 2012 Sep; 22(9):1383-90. PubMed ID: 22932293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Fusaro M; D'Arrigo G; Pitino A; Iervasi G; Tentori F; Robinson B; Aghi A; Bieber B; Mccullogh K; Fabris F; Plebani M; Giannini S; Gallieni M; Tripepi G
    J Bone Miner Res; 2019 Dec; 34(12):2238-2245. PubMed ID: 31365145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of proton pump inhibitors and risk of osteoporosis-related fractures.
    Targownik LE; Lix LM; Metge CJ; Prior HJ; Leung S; Leslie WD
    CMAJ; 2008 Aug; 179(4):319-26. PubMed ID: 18695179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.
    Gray SL; LaCroix AZ; Larson J; Robbins J; Cauley JA; Manson JE; Chen Z
    Arch Intern Med; 2010 May; 170(9):765-71. PubMed ID: 20458083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.
    Kendler DL; Marin F; Geusens P; López-Romero P; Lespessailles E; Body JJ; Minisola S
    Bone; 2020 Jan; 130():115113. PubMed ID: 31654779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association and Mechanisms of Proton Pump Inhibitors Use with Type-2Diabetes Mellitus Incidence in Adults: A Systemic Review andMeta-Analysis.
    Chenchula S; Sharma P; Ghanta MK; Amerneni KC; Rajakarunakaran P; Saggurthi P; Chandra MB; Gupta R; Chavan M
    Curr Diabetes Rev; 2024; 20(10):e120124225581. PubMed ID: 38243950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiazolidinediones and fractures: evidence from translating research into action for diabetes.
    Bilik D; McEwen LN; Brown MB; Pomeroy NE; Kim C; Asao K; Crosson JC; Duru OK; Ferrara A; Hsiao VC; Karter AJ; Lee PG; Marrero DG; Selby JV; Subramanian U; Herman WH
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4560-5. PubMed ID: 20631021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?
    Bazelier MT; Gallagher AM; van Staa TP; Cooper C; Leufkens HG; Vestergaard P; de Vries F
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):507-14. PubMed ID: 22392882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis.
    Lecka-Czernik B
    Curr Osteoporos Rep; 2010 Dec; 8(4):178-84. PubMed ID: 20809203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skeletal consequences of thiazolidinedione therapy.
    Grey A
    Osteoporos Int; 2008 Feb; 19(2):129-37. PubMed ID: 17901911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
    Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
    Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between proton pump inhibitor adherence and fracture risk in the elderly.
    Ding J; Heller DA; Ahern FM; Brown TV
    Calcif Tissue Int; 2014 Jun; 94(6):597-607. PubMed ID: 24706060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of genital and urinary tract infections associated with SGLT-2 inhibitors as an add-on therapy to metformin in patients with type 2 diabetes mellitus: A retrospective cohort study in Korea.
    Yang H; Choi E; Park E; Na E; Chung SY; Kim B; Han SY
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00910. PubMed ID: 35005849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study.
    Chan CW; Yu CL; Lin JC; Hsieh YC; Lin CC; Hung CY; Li CH; Liao YC; Lo CP; Huang JL; Lin CH; Wu TJ
    Cardiovasc Diabetol; 2018 Jan; 17(1):20. PubMed ID: 29368615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study.
    Moberg LM; Nilsson PM; Samsioe G; Borgfeldt C
    Maturitas; 2014 Aug; 78(4):310-5. PubMed ID: 24958166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoporosis and risk of fracture in patients with diabetes: an update.
    Montagnani A; Gonnelli S; Alessandri M; Nuti R
    Aging Clin Exp Res; 2011 Apr; 23(2):84-90. PubMed ID: 21743287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.